FCGR3A-eiwit (C-His, mens)

FCGR3A

CD16, CD16-II, CD16A, FCG3, FcgammaRIIIa, FCGR3, FCGRIII, FcGRIIIA, FCR-10, FCRIII, FCRIIIA, IGFR3, IMD20

C-His

< 0.5 EU per mg protein.

≥ 90 % as determined by SDS-PAGE. ≥ 90 % as determined by SEC-HPLC. ≥ 90 % as determined by SEC-MALS (Routinely tested) .

1.Loaded Recombinant Human CD16a / FCGR3A Protein (176 Phe, His Tag) (Cat. No. 10389-H08H-UE) on His1K Biosensor, can bind Anti-VEGF (Research Grade Bevacizumab Biosimilar) with an affinity constant of 0.112 μM as determined in BLI assay (Sartorius Octet RED384) (Routinely tested) . 2.Recombinant Human CD16a / FCGR3A Protein (176 Phe, His Tag) (Cat: 10389-H08H-UE) captured on CM5 chip via Anti-His antibody, can bind Anti-CD20 (Research Grade Rituximab Biosimilar) with an affinity constant of 0.549 μM as determined in an SPR assay (Biacore T200) (Routinely tested) .

Met 1-Gln 208

The secreted recombinant human CD16a consists of 203 amino acids and has a predicted molecular mass of 23.3 kDa. As a result of glycosylation, it migrates as an approximately 40-55 kDa band in SDS-PAGE under reducing conditions. The molecular weight of this protein is around 37.6 kDa verified by SEC-MALS (Routinely tested) .

Human